Document is current
Any future updates will be listed below
-
Authors
Shen, Yang
Connolly, Erin
Aiello, Meili
Zhou, Chengjing
Chappa, Prasanthi
Song, Haorui https://orcid.org/0009-0005-6940-9298
Tippitak, Patan
Clark, Tarralyn
Cardenas, Maria https://orcid.org/0000-0002-8566-9576
Prokhnevska, Nataliya
Mariniello, Annapaola
De Bruyker, Isabelle https://orcid.org/0009-0004-0540-495X
Pagadala, Meghana S.
Dhere, Vishal R. https://orcid.org/0000-0002-8364-7488
Rafiq, Sarwish https://orcid.org/0000-0002-9295-3065
Kesarwala, Aparna H. https://orcid.org/0000-0001-8297-9643
Orthwein, Alexandre https://orcid.org/0000-0002-7350-3413
Thomas, Susan N.
Zhang, Shirley L.
Khan, Mohammad K.
Dixon, J. Brandon https://orcid.org/0000-0003-0351-4587
Lesinski, Gregory B. https://orcid.org/0000-0002-8787-7678
Lowe, Michael C. https://orcid.org/0000-0003-4853-7352
Kissick, Haydn https://orcid.org/0000-0001-7624-5598
Yu, David S.
Paulos, Chrystal M. https://orcid.org/0000-0002-0784-2601
Schmitt, Nicole C. https://orcid.org/0000-0002-0571-3531
Buchwald, Zachary S. https://orcid.org/0000-0003-4407-7264
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (5K08CA270401-02)
- License Information
-
More Information
Article History
Received: 12 February 2024
Accepted: 19 March 2025
First Online: 14 April 2025
Competing interests
: N.C.S. has a consulting role at Checkpoint Surgical, Sensorion, and Synergy Research, Inc, is a member of the advisory board of Regeneron, receives book royalties from Plural Publishing, and has received funding from Astex Pharmaceuticals. G.B.L. has received research funding through a sponsored research agreement between Emory University and Merck and Co., Bristol-Myers Squibb, Boerhinger-Ingelheim, and Vaccinex. The remaining authors declare no competing interests.
